Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Type 2 Diabetes
TYPE 2 DIABETES
-
-
In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D
Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes. -
Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?
Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD on the risk of developing T2D. -
Addressing Psychological Insulin Resistance in Patients With Diabetes
Learn about strategies to reduce a patient’s reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.
Video
Latest News
Severe T2D With Insulin Resistance May Complicate Rheumatoid Arthritis Cases
Rheumatoid arthritis and osteoarthritis patients can experience poorly controlled severe type 2 diabetes, say French researchers who suggest considering targeting insulin resistance through treatment for joint and systemic inflammation.
Patients With Type 2 Diabetes Have Trabecular Bone Fragility Due to Alterations in Bone Structure and Composition
Patients with type 2 diabetes face up to a three-fold increased risk of hip fracture, despite adequate areal bone mineral density which may underestimate fracture risk in these patients.
Type 1 and Type 2 Diabetes Increases Risk for Severe or Fatal COVID-19 Infection
In addition to a diabetes diagnosis, people with a history of smoking and who have specific comorbidities, such as heart disease, liver disease, and chronic lower respiratory disease, are at increased risk of poorer COVID-19 outcomes.
Endocrine Society Makes Recommendations to Reduce the Cost of Insulin
The Endocrine Society is calling for immediate action by policymakers to address the underlying factors responsible for the rising cost of insulin, a life-saving drug taken by 7.4 million people in the United States.
Diabetes Complications May Vary Considerably by Race and Ethnicity
The severity of complications from diabetes appear to differ by race and ethnicity.
Healthcare Organizations Must Dig Deep to Close the Gap in Minority Health Inequity
In a statement published in the Journal of Clinical Endocrinology and Metabolism, physicians from Johns Hopkins School of Medicine acknowledge the challenges minority populations may face within the healthcare system. They pose a larger question: Why does disparity exist?
Uncontrolled Hypertension May Contribute to Cognitive Deficits Over Time
Study researchers evaluated whether hypertension and prehypertension could predict greater decline in cognitive performance.
Glycemic Control, Regardless of Diabetes Status, May Be Associated With Increased COVID-19 Mortality
Fasting glucose levels and glycemic fluctuations have been found to be independently associated with poor prognosis in adults hospitalized for COVID-19—regardless of diabetes status.
OCT-A Scans Can Predict Worsening Diabetic Eye Disease
Monitoring changes at 2 retinal biomarkers, OCT-A can foretell visual outcomes and retinal sensitivity.
Rheumatic Disease, Biologic DMARDs, and Diabetes: Is There a Link?
A deeper insight into the association between treatment with biologic disease-modifying antirheumatic drugs in rheumatic diseases and risk for type 2 diabetes.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Type 2 Diabetes
